US Patent Issued to Arsenal Biosciences on July 14 for "Synthetic pathway activators" (Pennsylvania, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,881, issued on July 14, was assigned to Arsenal Biosciences Inc..

"Synthetic pathway activators" was invented by Levi Gray-Rupp (Philadelphia), Thomas Gardner (South San Francisco, Calif.) and Anzhi Yao (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are novel synthetic pathway activators comprising multimerization regions, transmembrane domains, and intracellular signaling domains."

The patent was filed on May 7, 2025, under Application No. 19/201,822.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fn...